Intellectual Property

CDG Therapeutics' intellectual property includes 13 patents issued between 2006 and 2011 on the founders' core technology and improvements:

Patent # 7084105
Patent # 7301010
Patent # 7338766
Patent # 7381701
Patent # 7491394
Patent # 7511117
Patent # 7556810
Patent # 7618939
Patent # 7691383
Patent # 7740857
Patent # 7795410
Patent # 7807183
Patent # 7888468

Additionally, CDG has 23 pending/non-provisional patents and PCT applications. www.USPTO.gov

Our patents include composition of matter including modifications thereof, utility claims as a single or multiple-agent therapy; therapeutic adjunct; and for diagnostic uses. The portfolio includes indications for cancer as well as allied and infectious diseases.